The decision by the Center for Disease Control and Prevention to stop recommending giving infants a dose of the hepatitis B ...
The revised guidelines also will lead to more than $20 million in extra health care costs, the research shows.
Add Yahoo as a preferred source to see more of our stories on Google. The CDC's Advisory Committee on Immunization Practices is expected to vote to recommend delaying the hepatitis B shot typically ...
Researchers found that the decision to delay the once-universal hepatitis B shot for babies will likely cause a surge in ...
The hepatitis B vaccine has emerged as the latest flashpoint as Health Secretary Robert F. Kennedy Jr. continues to cast doubt on the safety of vaccines. The vaccine is routinely given to babies ...
Nearly 287 million people worldwide live with hepatitis B or C, yet most remain undiagnosed until severe liver damage occurs.
Federal vaccine advisers to Health Secretary Robert F. Kennedy Jr. voted in December to recommend delaying the first shot ...
Many medical organizations and frontline health care providers are grappling with a challenge they haven't had to face in many years: how to protect newborns against hepatitis B.Last week, a federal ...
GSK today announced that it has filed a new drug submission for bepirovirsen for regulatory review in Canada. Bepirovirsen is ...
Phase 3 trial results demonstrate that bepirovirsen significantly increases the proportion of patients achieving functional cure compared with placebo.
The CDC's Advisory Committee on Immunization Practices is expected to vote to recommend delaying the hepatitis B shot typically given at birth to age 4. Do newborns need the hepatitis B vaccine to B ...